● Investor
Frazier Life Sciences
Healthcare investment firm focusing on novel therapeutics, company creation and biopharmaceutical development across all stages
Venture CapitalMenlo Park, United StatesSeries F → Series B
Portfolio
2
companies tracked
Rounds · 12mo
2
participated in
Est. deployed · 12moEstimated by summing amounts of tracked rounds. Actual check sizes vary and often aren't disclosed.
$430M
sum of tracked rounds
Top stage
Series B
by round count
Recent activity
Rounds LatestRounds has tracked from this investor.
Where they invest
By stage · rounds, 12mo
Series B1
Series F1
Frequent co-investors
No repeat co-investors yet.